Harmony Biosciences Holdings, Inc.HRMYNASDAQ
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank30
3Y CAGR-42.5%
5Y CAGR-40.1%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
-42.5%/yr
Quarterly compound
5Y CAGR
-40.1%/yr
Consistent
Percentile
P30
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 1.80% |
| Q3 2025 | 19.44% |
| Q2 2025 | 8.53% |
| Q1 2025 | -8.21% |
| Q4 2024 | 8.19% |
| Q3 2024 | 7.65% |
| Q2 2024 | 11.77% |
| Q1 2024 | -8.19% |
| Q4 2023 | 5.08% |
| Q3 2023 | 19.41% |
| Q2 2023 | 12.67% |
| Q1 2023 | -7.16% |
| Q4 2022 | 9.47% |
| Q3 2022 | 9.51% |
| Q2 2022 | 25.45% |
| Q1 2022 | -6.47% |
| Q4 2021 | 12.98% |
| Q3 2021 | 9.36% |
| Q2 2021 | 23.71% |
| Q1 2021 | 6.02% |
| Q4 2020 | 23.41% |
| Q3 2020 | 20.01% |
| Q2 2020 | 91.56% |
| Q1 2020 | 230.94% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |